PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Detail   |   Print    Next page > 
     
The Second Battlefield for Solid Tumor CAR-T: A Global Race in the Intracranial Arena -- Who Is Leading?
2026-07-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Alebund Pharmaceuticals Announces First Participant Randomized and Dosed in Global Phase IIb Multi-Regional Clinical Trial of AP306 for Hyperphosphatemia
2026-07-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Takeda's Dengue Vaccine (TAK-003) Becomes India's First Approved Dengue Vaccine, Bringing Prevention to One of the World's Most At-Risk Populations
2026-07-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Haier Biomedical Presents Digital Blood Management Platform at ISBT Congress 2026, Advancing Its Transition from Equipment Provider to Full-Process Solution Partner
2026-07-21T    Biotechnology   Computer Software   Computer/Electronics   Health Care/Hospital 
MALAYSIA HEALTHCARE BROUGHT MALAYSIA'S LEADING HOSPITALS TO HONG KONG'S MOST INFLUENTIAL HEALTHCARE AUDIENCE
2026-07-21T    Health Care/Hospital   Medical/Pharmaceuticals   Travel   Trade show news 
Ping An Unveils Innovative AI Solutions in Healthcare, Insurance and Payments at WAIC 2026
2026-07-21T    Banking/Financial Service   Computer Software   Computer/Electronics   Health Care/Hospital 
Rege Nephro Secures approximately US$10.6 Million to Advance RN-014 Toward Commercialization
2026-07-21T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
ESMO 2026 | Mabwell to Present Latest Clinical Data on Nectin-4-targeting ADC 9MW2821 for Triple Negative Breast Cancer in Oral Presentation
2026-07-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
SuanNutra, Parent Company of Monteloeder and a Carbyne Equity Partners Portfolio Company, Expands Product Portfolio with Specialty Natural Ingredients Businesses from IFF
2026-07-21T    Chemical   Food/Beverages   Health Care/Hospital   Medical/Pharmaceuticals 
Telix Q2 Revenue US$247M, Strong Momentum and Pipeline Progress
2026-07-21T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved